As a result, 8.9% and 43% of the patients achieved the Hb goals according to the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) and KDIGO, respectively. Here, GSTM1 is linked to kidney disorder.